THE VALUE OF SALICYLATES IN PREVENTION OF RHEUMATIC MANIFESTATIONS
- 27 September 1930
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 95 (13) , 932-934
- https://doi.org/10.1001/jama.1930.02720130028009
Abstract
Statistical evidence in regard to the value of the salicylates as a preventive of the recurrence of rheumatic disorders is meager. It has been the custom in some clinics to give to patients with inactive rheumatic heart disease rations of salicylates in the hope that such a procedure might prove beneficial in the prevention of recurrences and exacerbations. In the autumn of 1928, certain patients attending the cardiac clinic in the Harriet Lane Home of the Johns Hopkins Hospital were selected for the purpose of a study of the effect of constant salicylate ingestion. Patients with inactive rheumatic heart lesions were divided into two groups, one of which received salicylates daily for a period of six months; the other group received no salicylates and acted as a control. Similarly, children with potential heart disease, that is, children who had had one or more attacks of chorea or rheumatic fever butKeywords
This publication has 0 references indexed in Scilit: